REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
10.38
+1.73 (20.00%)
At close: Mar 9, 2026, 4:00 PM EDT
10.18
-0.20 (-1.93%)
Pre-market: Mar 10, 2026, 6:22 AM EDT
REGENXBIO Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -193.88 | -227.1 | -263.49 | -280.32 | 127.84 | |
| Depreciation & Amortization | 15.62 | 16.22 | 17.32 | 12.91 | 9.56 | |
| Asset Writedown & Restructuring Costs | - | 2.1 | - | - | - | |
| Loss (Gain) From Sale of Investments | -5.54 | -10.76 | -1.52 | 4.79 | 0.65 | |
| Stock-Based Compensation | 34.56 | 38.46 | 40.27 | 40.79 | 38.81 | |
| Provision & Write-off of Bad Debts | - | -5 | - | - | -2.57 | |
| Other Operating Activities | 13.5 | 7.43 | -0.1 | 0.37 | 4.36 | |
| Change in Accounts Receivable | -7.66 | 9.71 | 3.94 | 4.82 | 14.12 | |
| Change in Accounts Payable | -2.28 | -0.29 | -2.79 | 18.79 | -2.3 | |
| Change in Unearned Revenue | 29.28 | -0.03 | -1.51 | -1.17 | -0.9 | |
| Change in Other Net Operating Assets | -7.56 | -3.85 | -10.52 | -8.47 | 29.3 | |
| Operating Cash Flow | -123.96 | -173.13 | -218.41 | -207.49 | 218.88 | |
| Capital Expenditures | -2.41 | -2.44 | -9.96 | -30.72 | -84.18 | |
| Investment in Securities | -13.45 | 105.88 | 200.9 | 18.8 | -322.47 | |
| Investing Cash Flow | -15.87 | 103.45 | 190.94 | -11.93 | -406.64 | |
| Issuance of Common Stock | 1.37 | 133.77 | 8.22 | 4.55 | 222.49 | |
| Repurchase of Common Stock | -0.63 | -0.91 | -0.42 | -0.28 | -0 | |
| Other Financing Activities | 116.04 | -40.18 | -42.77 | -33.1 | -27.24 | |
| Financing Cash Flow | 116.77 | 92.68 | -34.97 | -28.84 | 195.25 | |
| Net Cash Flow | -23.06 | 23 | -62.43 | -248.26 | 7.48 | |
| Free Cash Flow | -126.38 | -175.56 | -228.37 | -238.21 | 134.7 | |
| Free Cash Flow Margin | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% | |
| Free Cash Flow Per Share | -2.45 | -3.55 | -5.22 | -5.52 | 3.07 | |
| Cash Interest Paid | 32.11 | 6.56 | 7.28 | 23.12 | 21.64 | |
| Cash Income Tax Paid | 0.29 | -0.07 | -0.14 | 11.81 | 6 | |
| Levered Free Cash Flow | -79.79 | -95.45 | -133.51 | -156.11 | 72.51 | |
| Unlevered Free Cash Flow | -51.66 | -87.54 | -129.22 | -141.58 | 88.93 | |
| Change in Working Capital | 11.78 | 5.53 | -10.89 | 13.98 | 40.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.